Tasly: The company's liver disease drug Shuilinjia is indicated for the recovery of abnormal liver function in patients with acute and chronic hepatitis and fatty liver.

Post date May 8, 2022 — 20:38 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

Experimental monkey trapped in time-Titanium Media Official Website

May 20, 2022 — 16:55

"I don't think it's unusual for a monkey to rise to 200,000"

May 20, 2022 — 16:55

Zhongsheng Pharmaceutical was investigated by 13 institutions: Fufang Xueshuantong Capsule and Naoshuantong Capsule strengthened evidence-based evidence through medical research and obtained high-quality clinical research results (with survey questions and answers)

May 20, 2022 — 16:00

A number of companies have clarified that "there is no fenugreek"! Beware of second-degree speculation in risk concept stocks_Sina Finance_Sina.com

May 17, 2022 — 15:02

A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation CFi.CN Zhongcai Network

May 17, 2022 — 14:57

Pleco’s fixed increase of no more than 900 million has been approved by the China Securities Regulatory Commission and has been approved by Huatai Joint Construction.

May 17, 2022 — 14:56

Pleco's fixed increase of no more than 900 million was approved by the China Securities Regulatory Commission

May 17, 2022 — 14:56

Pleco’s fixed increase of no more than 900 million has been reviewed and approved by the China Securities Regulatory Commission.

May 17, 2022 — 14:55

A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation

May 17, 2022 — 14:10

Home » News » Tasly: The company's liver disease drug Shuilinjia is indicated for the recovery of abnormal liver function in patients with acute and chronic hepatitis and fatty liver.